We are live on ! Find out more
PCA

Peddock Capital Advisors Portfolio holdings

AUM $501M
1-Year Est. Return 29.8%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$195M
AUM Growth
+$15.2M
Cap. Flow
+$5.76M
Cap. Flow %
2.95%
Top 10 Hldgs %
51.17%
Holding
249
New
137
Increased
22
Reduced
54
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$499K
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$490K
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$211K
4
WFC icon
Wells Fargo
WFC
+$205K
5
SHW icon
Sherwin-Williams
SHW
+$200K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$983K
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$237K
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$218K
4
PFE icon
Pfizer
PFE
+$150K
5
HPQ icon
HP
HPQ
+$146K

Sector Composition

Rank Sector Weight
1 Energy 32.45%
2 Technology 12.69%
3 Financials 8.54%
4 Healthcare 6.73%
5 Consumer Staples 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
76
Alphabet (Google) Class C
GOOG
$4.08T
$440K 0.23%
6,580
– –
LHX icon
77
L3Harris
LHX
$56.9B
$432K 0.22%
2,183
– –
AGN
78
DELISTED
Allergan plc
AGN
$416K 0.21%
2,174
– –
SNPS icon
79
Synopsys
SNPS
$73B
$415K 0.21%
2,983
– –
IJR icon
80
iShares Core S&P Small-Cap ETF
IJR
$110B
$378K 0.19%
4,504
-1,401
-24% -$113K
CB icon
81
Chubb
CB
$141B
$354K 0.18%
2,272
– –
CARG icon
82
CarGurus
CARG
$3.26B
$352K 0.18%
10,000
– –
COP icon
83
ConocoPhillips
COP
$139B
$344K 0.18%
5,291
-270
-5% -$15.9K
ZTS icon
84
Zoetis
ZTS
$32.5B
$343K 0.18%
2,593
-117
-4% -$14.5K
IWF icon
85
iShares Russell 1000 Growth ETF
IWF
$119B
$341K 0.17%
7,748
-376
-5% -$15.7K
BNY
86
Bank of New York Mellon
BNY
$107B
$339K 0.17%
6,740
– –
T icon
87
AT&T
T
$169B
$308K 0.16%
10,452
– –
CLH icon
88
Clean Harbors
CLH
$16B
$300K 0.15%
3,500
– –
BSX icon
89
Boston Scientific
BSX
$68.8B
$298K 0.15%
6,581
– –
ABBV icon
90
AbbVie
ABBV
$470B
$297K 0.15%
3,350
– –
V icon
91
Visa
V
$702B
$291K 0.15%
1,547
-213
-12% -$38.4K
BRK.B icon
92
Berkshire Hathaway Class B
BRK.B
$1.1T
$285K 0.15%
1,259
– –
EMR icon
93
Emerson Electric
EMR
$84.6B
$284K 0.15%
3,730
– –
NVS icon
94
Novartis
NVS
$304B
$284K 0.15%
2,996
– –
SPY icon
95
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$275K 0.14%
855
– –
ABT icon
96
Abbott
ABT
$187B
$266K 0.14%
3,058
– –
TJX icon
97
TJX Companies
TJX
$177B
$258K 0.13%
4,220
– –
MO icon
98
Altria Group
MO
$125B
$257K 0.13%
5,144
+3
+0.1% +$142
ALXN
99
DELISTED
Alexion Pharmaceuticals
ALXN
$254K 0.13%
2,346
-166
-7% -$17.8K
CLX icon
100
Clorox
CLX
$12.1B
$246K 0.13%
1,600
– –
2 3
4
5 6

Similar funds

CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
HSG
Helen Stephens Group Fort Worth, Texas $501M AUM 16.23% 1-Year Est. Return
DAC
Dividend Assets Capital Ridgeland, South Carolina $501M AUM 13.71% 1-Year Est. Return
AA
Auxano Advisors Bellevue, Washington $501M AUM 24.15% 1-Year Est. Return
MCCP
Mission Creek Capital Partners San Francisco, California $501M AUM 28.4% 1-Year Est. Return
SWA
Serenus Wealth Advisors Santa Monica, California $501M AUM 10.41% 1-Year Est. Return
PRP
Peak Retirement Planning Columbus, Ohio $501M AUM 14.34% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Peddock Capital Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Peddock Capital Advisors held 249 positions worth $195M, up 8.4% from $180M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Peddock Capital Advisors's Q4 2019 filing shows 137 new, 22 increased, 54 reduced and 1 closed positions. Its largest new stake was Wells Fargo: 3,905 shares worth $210K. The largest sale was Celgene Corp, an estimated $983K.

By sector, the portfolio is most concentrated in Energy at 32% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Peddock Capital Advisors's largest Q4 2019 buy was Wells Fargo: 3,905 shares worth $210K.
  • Peddock Capital Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $499K increase.
  • Peddock Capital Advisors's biggest Q4 2019 reduction was iShares S&P 500 Growth ETF, cutting an estimated $237K.
  • Peddock Capital Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $983K.
  • Peddock Capital Advisors's ten largest holdings make up 51% of its $195M portfolio in Q4 2019.
  • Peddock Capital Advisors opened 137 new positions and closed 1 in Q4 2019.
  • Peddock Capital Advisors's portfolio value rose 8.4% quarter-over-quarter to $195M.

Based on Peddock Capital Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.